Abstract
COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
Keywords: Quercetin, therapeutic, COVID-19, ACE2, SARS, MERS.
Current Molecular Medicine
Title:Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview
Volume: 21 Issue: 5
Author(s): Saiyad Bastaminejad and Salar Bakhtiyari*
Affiliation:
- Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam,Iran
Keywords: Quercetin, therapeutic, COVID-19, ACE2, SARS, MERS.
Abstract: COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
Export Options
About this article
Cite this article as:
Bastaminejad Saiyad and Bakhtiyari Salar *, Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview, Current Molecular Medicine 2021; 21 (5) . https://dx.doi.org/10.2174/1566524020999200918150630
DOI https://dx.doi.org/10.2174/1566524020999200918150630 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pan-Vertebrate Toll-Like Receptors During Evolution
Current Genomics Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets Targeting Toll-like Receptors in Autoimmunity
Current Drug Targets Editorial [Hot Topic: Protective or Damaging Immunity in Infection (Guest Editors: Jose Gutierrez and Antonio Sorlozano)]
Current Immunology Reviews (Discontinued) Structural and Functional Diversity of Glutaredoxins in Yeast
Current Protein & Peptide Science Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Possibilities of Poly(D,L-lactide-co-glycolide) in the Formulation of Nanomedicines Against Cancer
Current Drug Targets Immunity to Bacterial Infections
Current Immunology Reviews (Discontinued) Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPARα, PPARγ, and PPARδ
Current Diabetes Reviews ATP Binding Cassette Transporter A1 (ABCA1) Associated Proteins:Potential Drug Targets in the Metabolic Syndrome and Atherosclerotic Disease?
Current Pharmaceutical Biotechnology Therapeutic Targeting of G-Protein Coupled Receptor-Mediated Epidermal Growth Factor Receptor Transactivation in Human Glioma Brain Tumors
Mini-Reviews in Medicinal Chemistry Challenges in the Discovery and Optimization of mGlu2/4 Heterodimer Positive Allosteric Modulators
Letters in Drug Design & Discovery Alzheimer’s Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Current Alzheimer Research Osteoarthritis - Current Insights in Pathogenesis, Diagnosis and Treatment
Current Rheumatology Reviews Microemulsions as Carriers for Therapeutic Molecules
Recent Patents on Drug Delivery & Formulation Systems Biology and Biomechanical Model of Heart Failure
Current Cardiology Reviews Non-Systemic Drugs: A Critical Review
Current Pharmaceutical Design Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies
Current Topics in Medicinal Chemistry Immunological Aspects of the Prostate Gland and Related Diseases
Current Immunology Reviews (Discontinued) Epidural Analgesia in the Post-Anaesthesia Care Unit
Current Drug Targets